RECALL: Pfizer recalls some blood pressure drugs nationwide over potential cancer risk. To date, Pfizer is not aware of reports of adverse events that have been assessed to be related to this recall, it said in the recall notice.
The drug manufacturer said Monday that it was pulling six lots of Accuretic tablets, one lot of quinapril and hydrochlorothiazide tablets and four lots of quinapril HCI/hydrochlorothiazide tablets -- all hypertension treatments -- in the U.S. recall.
Nitrosamines are common in water and foods, including cured and grilled meats, dairy products and vegetables, meaning virtually everyone is exposed to some level of the chemical, Pfizer said. The"impurities" could increase cancer risk if people are exposed to them above acceptable levels over long periods of time, research says.
Pfizer says it believes the benefit of its recalled blood pressure-lowering medications outweighs the risk associated with the nitrosamine found in them , based on currently available data.
Norge Siste Nytt, Norge Overskrifter
Similar News:Du kan også lese nyheter som ligner på denne som vi har samlet inn fra andre nyhetskilder.
Pfizer recalls some blood pressure drug products over elevated levels of cancer-causing impurityPfizer said it was recalling some blood pressure medication and two generic versions Monday over elevated levels of a cancer-causing impurity.
Les mer »
Pfizer recalls blood pressure medicines over carcinogenThe impurity is common in water and food like cured and grilled meats, dairy and vegetables, but it could increase the risk of cancer if you’re exposed to too much for too long.
Les mer »
Pfizer recalls some lots of blood pressure drug due to potential carcinogenPfizer Inc said on Monday it was recalling some lots of blood pressure drug Accuretic and two authorized cheaper versions of the drug due to the presence of elevated levels of a nitrosamine, a potential cancer-causing impurity.
Les mer »
Pfizer Recalls BP Drugs Due to Potential Cancer Risk🚨DRUG RECALL ALER🚨: Drug giant Pfizer is voluntarily recalling some high blood pressure medications due to unacceptable levels of a potential carcinogen, the company announced.
Les mer »